BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36602927)

  • 1. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS
    J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy.
    Wade RL; Kindermann SL; Hou Q; Thase ME
    J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
    Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
    Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.
    Forsberg L; Navér L; Gustafsson LL; Wide K
    PLoS One; 2014; 9(11):e111327. PubMed ID: 25365553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC; Saccone G; Berghella V
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
    Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
    Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
    Orlova Y; Rizzoli P; Loder E
    JAMA Neurol; 2018 May; 75(5):566-572. PubMed ID: 29482205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSRI/SNRI -induced Hyponatremia: A Case Series of 26 Patients in a Single Institution from 2018 to 2020.
    Zhao Z; Zhao F; Jin P; Hu X; Tian C; Liu D; Zhang Y
    Psychiatr Q; 2023 Jun; 94(2):113-125. PubMed ID: 36913163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
    Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
    BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting.
    Kern DM; Cepeda MS; Castilla-Puentes RC; Savitz A; Etropolski M
    Curr Med Res Opin; 2021 Aug; 37(8):1377-1384. PubMed ID: 33818238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database.
    Benevent J; Araujo M; Karki S; Delarue-Hurault C; Waser J; Lacroix I; Tebeka S; Damase-Michel C
    J Clin Psychiatry; 2023 Jul; 84(4):. PubMed ID: 37437238
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
    Khanassov V; Hu J; Reeves D; van Marwijk H
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
    Lund N; Pedersen LH; Henriksen TB
    Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case-control study.
    Rosenberg T; Lattimer R; Montgomery P; Wiens C; Levy L
    Clin Interv Aging; 2017; 12():1977-1984. PubMed ID: 29200837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.